Certified Global Research Member

Key Questions Answered

Global Market Outlook
In-depth analysis of global and regional trends
Analyze and identify the major players in the market, their market share, key developments, etc.
To understand the capability of the major players based on products offered, financials, and strategies.
Identify disrupting products, companies, and trends.
To identify opportunities in the market.
Analyze the key challenges in the market.
Analyze the regional penetration of players, products, and services in the market.
Comparison of major playersâ€™ financial performance.
Evaluate strategies adopted by major players.
Recommendations

Why Choose Market Research Future?

Vigorous research methodologies for specific market.
Knowledge partners across the globe
Large network of partner consultants.
Ever-increasing/ Escalating data base with quarterly monitoring of various markets
Trusted by fortune 500 companies/startups/ universities/organizations
Large database of 5000+ markets reports.
Effective and prompt pre- and post-sales support.

Microcrystalline Cellulose MCC Market Share

ID: MRFR//4165-CR | 169 Pages | Author: Anshula Mandaokar| March 2021

Due to its high binding capacity, microcrystalline cellulose (MCC) finds extensive use in medication formulations. The production of pharmaceuticals, especially those in the form of capsules and oral tablets, relies on it as a binder and filler (diluent). Several procedures make use of MCC, including direct compression and wet granulation. Indeed, it ranks high among the excipients utilized for direct compression. Other and no less important than MCC as disintegrant and lubricant material in drug formulations is MCC with properties like low coefficient of friction and low residual die wall pressure.

Increased global demands for the processed foods is main force for the microcrystalline cellulose market. The increasing demand for processed foods has resulted in a relatively high deployment of MCC as an ingredient that has subsequently developed the market. Apart from its function in processed foods, the predictable rise in demand for the MCC is attributed to the increase in demand for the pharmaceutical goods like tablets and capsules as well. However, the market expansion faces problems although these trends are quite encouraging, e.g. volatility of price and competition with other products. Yet, due to the higher disposable income support in the developing countries of Asia-Pacific, new prospects are being created for the global corporations.

Microcrystalline cellulose is excellent in its binding and filling properties, this property makes it play a key role in drug formulation by improving the overall diagram and behavior of the capsules and tablets Wet granulation as well as direct compession (another critical pharmaceutical method) are the processes based on this, and MCC is the most preferred excipient in the latter. icularly, MCC stands out for exhibiting both low coefficient of friction and low die wall pressure residuals, while serving as a lubricant and dissociator ensuring proper pharmaceutical product performance.

Microcrystalline cellulose industry is more dependent on the trends changing in consumer's dietary pattern in the world. A steady growth of the global processed food consumption has been observed, and it results in an increased use of MCC as a flavoring. This has been a key factor to the market's steadfast growth. With the increasing demand, and health concerns the MCC will need to be able to provide more capsules and tablet products. In spite of that some challenges still remain in existence and these include the price fluctuations and the easily available alternatives although there are some encouraging signs.

Examples of new business opportunities exist for major microcrystalline cellulose companies on the market. The rapidly developing area where there is a median class is a suitable place for these companies to trade. Future prospects of the microcrystalline cellulose market are rosy as the demand for processed foods, medicine and the likes, is expected to increase these regions, especially as the middle class grows.

To summarize, microcrystalline cellulose is a major player in the worldwide market because of its many uses in processed foods, pharmaceuticals, and as a binder and filler in medicinal formulations. The microcrystalline cellulose industry faces obstacles, but it has a bright outlook due to the possibility for expansion, particularly in developing nations.

Covered Aspects:

Report Attribute/Metric	Details
Base Year For Estimation	2021
Historical Data	2018 & 2020
Forecast Period	2022-2030
Growth Rate	6.78% (2022-2030)

Microcrystalline Cellulose MCC Market Highlights:

Microcrystalline Cellulose MCC Market Trends

Microcrystalline Cellulose MCC Market Analysis

Microcrystalline Cellulose MCC Market Share

Microcrystalline Cellulose MCC Companies

Global Microcrystalline Cellulose Market Overview

The microcrystalline cellulose market size was valued at USD 1.28 billion in 2023. The microcrystalline cellulose industry is projected to grow from USD 1.36 Billion in 2024 to USD 2.35 billion by 2032, exhibiting a compound annual growth rate (CAGR) of 7.00% during the forecast period (2024 - 2030). Increasing application of microcrystalline cellulose in various industries and growing awareness about health are the key market drivers enhancing the market growth.

Microcrystalline Cellulose Market Overview
Source: Secondary Research, Primary Research, MRFR Database and Analyst Review

Microcrystalline Cellulose Market Trends

Growing Pharmaceutical industry to boost the market growth

Microcrystalline cellulose is used in the pharmaceutical industry as a stabilizer, binder, film-forming agent, suspension agent, and disintegrate in tablet formulations, ointments, and other topical therapeutic bases. MCC is one of the most important and widely used excipients in the pharmaceutical industry. It is a key diluent and is used as a binding agent in pharmaceutical formulations. It is extensively used in drug preparations such as tablets, capsules, sachets, and so on. The growing production of pharmaceutical products is further driving the market. Emerging countries such as China, Brazil, and India are the rapidly-growing the demand for microcrystalline cellulose market revenue.

Further, growth in consumption of processed foods across the globe majorly drives the market. Increase in consumption of processed food has augmented the use of MCC as an additive, which in turn boosts the market growth. Moreover, consumption of pharmaceutical products, such as tablets and capsules, is expected to fuel the demand for MCC. However, volatile prices and availability of substitute products have restricted the market growth. Conversely, rise in disposable income of population in developing economies in Asia-Pacific is anticipated to provide new opportunities for the key players.

Additionally, increasing application of microcrystalline cellulose in various industries is a major factor propelling growth of the microcrystalline cellulose market. For instance, microcrystalline cellulose is used as stabilizer, gelling agent, suspending agent, and anti-caking agent in beverages. It is also used as a cold and hot stabilizer, in frozen food, ice cream, and canned meat, in order to improve the shelf life of these products.

However, microcrystalline cellulose is widely used in pharmaceuticals, owing to its tastelessness, odorlessness, and chemical inertness properties. According to the International Trade Administration, in 2021, the market for pharmaceuticals is projected to grow from around US$ 1.22 trillion in 2021 to US$ 1.42 trillion by 2021. Steadily growing pharmaceutical industry is expected to support market growth of microcrystalline cellulose over the forecast period. Therefore, growing demand for pharmaceutical industry has enhanced the microcrystalline cellulose market CAGR across the globe in the recent years.

Microcrystalline Cellulose Market Segment Insights

Microcrystalline Cellulose Source Insights

The microcrystalline cellulose market segmentation, based on source, includes wood based, and non-wood based. The wood based segment held the majority share in 2021 to the microcrystalline cellulose market revenue. Growing applications in the pharmaceutical sector are expected to continue pushing sales in this segment over the forecast period. Pharma-grade microcrystalline cellulose is derived from wood pulp, where cellulose chains are arranged in layers held by lignin and string hydrogen bonds. Derived from cellulose hydrolysis, microcrystalline cellulose is then used as a diluent, offering superior binding properties and plasticity. However, non-wood based segment is the fastest-growing category over the forecast period. Growing awareness regarding carbon emission and rapid deforestation is underpinning the need for environment-friendly production processes and materials. This has led to the development of non-wood-based fibers and raw materials for microcrystalline cellulose production.

Microcrystalline Cellulose End-Use Industry Insights

The microcrystalline cellulose market data has been bifurcated by end-use industry into pharmaceuticals, food & beverages, and cosmetic & personal care. The pharmaceuticals segment dominated the market in 2021 and is projected to be the faster-growing segment during the forecast period, 2022-2030. This is attributed owing to high use of microcrystalline cellulose in pharmaceutical. This is due to its chemical inertness and dry binding properties. However, food & beverages is the fastest-growing category over the forecast period due to wide application of micro crystalline cellulose in various food and beverages including desserts, frozen food, dairy products, and baked goods. Hence, it is also used as a fat replacer and helps maintain food consistency positively impacts the market growth.

Figure 2: Microcrystalline Cellulose Market, by End-User Industry, 2021 & 2030 (USD Million)Source: Secondary Research, Primary Research, MRFR Database and Analyst Review

Microcrystalline Cellulose Regional Insights

By Region, the study provides the market insights into North America, Europe, Asia-Pacific and Rest of the World. Asia-Pacific microcrystalline cellulose market accounted for USD 0.47 billion in 2021 and is expected to exhibit a significant CAGR growth during the study period. This is attributed to steadily growing food and pharmaceutical industries as microcrystalline cellulose has high demand in pharmaceuticals and is extensively used as functional ingredient in food and beverages across the region. Moreover, China microcrystalline cellulose market held the largest market share, and the India microcrystalline cellulose market was the fastest growing market in the Asia-Pacific region.

Further, the major countries studied in the market report are: The U.S, Canada, Germany, France, UK, Italy, Spain, China, Japan, India, Australia, South Korea, and Brazil.

Figure 3: MICROCRYSTALLINE CELLULOSE MARKET SHARE BY REGION 2021 (%)Source: Secondary Research, Primary Research, MRFR Database and Analyst Review

Europe microcrystalline cellulose market accounts for the second-largest market share due to the increasing government-backed investments in drug development and improvements in the quality of pharmaceutical products are anticipated to bode well for the market in this region. Further, the Germany microcrystalline cellulose market held the largest market share, and the UK microcrystalline cellulose market was the fastest growing market in the European region.

The Asia-Pacific microcrystalline cellulose Market is expected to grow at the fastest CAGR from 2022 to 2030. This is due to the economic recovery and the increase in employment rate are the growth factors in the region, which, in turn, supports the growth of the market Moreover, China microcrystalline cellulose market held the largest market share, and the India microcrystalline cellulose market was the fastest growing market in the Asia-Pacific region.

Microcrystalline Cellulose Key Market Players & Competitive Insights

Major market players are spending a lot of money on R&D to increase their product lines, which will help the microcrystalline cellulose market grow even more. Market participants are also taking a range of strategic initiatives to grow their worldwide footprint, with key market developments such as new product launches, contractual agreements, mergers and acquisitions, increased investments, and collaboration with other organizations. Competitors in the microcrystalline cellulose industry must offer cost-effective items to expand and survive in an increasingly competitive and rising market environment.

One of the primary business strategies adopted by manufacturers in the microcrystalline cellulose industry to benefit clients and expand the market sector is to manufacture locally to reduce operating costs. In recent years, microcrystalline cellulose industry has provided medicine with some of the most significant benefits. The microcrystalline cellulose market major player such as DuPont, Asahi Kasei Corporation, JRS Pharma, Roquette Frères, and others are working to expand the market demand by investing in research and development activities.

Asahi Kasei Medical Co., Ltd. manufactures and distributes medical devices. The Company produces dialyzers, therapeutic apheresis products, leukocyte reduction filters, virus removal filters, and other products. Asahi Kasei Medical markets its products throughout Japan. In June 2022, Asahi Kasei Medical has completed its acquisition of Bionova Scientific, LLC, a provider of contract process development services and GMP-compliant contract manufacturing services to biopharmaceutical companies. Bionova Scientific will operate as a business unit within Asahi Kasei Medical’s bioprocess division. Bionova Scientific will continue to expand its business by building on its strengths as a CDMO specialized in the process design and manufacture of various types of biologics such as microcrystalline cellulose, cytokines, vaccines, hormones etc.

Also, DFE Pharma is a leader in pharma- and nutraceutical excipient solutions. The company develop, produce and supply high-quality functional excipients for use in the pharmaceutical, biopharmaceutical, and nutraceutical industries for respiratory, oral solid dose (OSD), ophthalmic and parenteral formulations. In July 2021, DFE Pharma, a provider of pharmaceutical Excipient solutions, launched Pharmacel sMCC 90, a silicified variant of microcrystalline cellulose. The new product is developed as a synergistic solution for challenging oral solid dosage formulations. It offers increases surface area, enhanced powder flow, and superior tablatibility, thereby improving formulation robustness.

Key Companies in the Microcrystalline Cellulose market includes

DuPont

Asahi Kasei Corporation

JRS Pharma

Roquette Frères

Mingtai Chemical Co., Ltd.

Accent Microcell Pvt. Ltd.

JRS Pharma

Pharmatrans-Sanaq AG

DFE Pharma

Weiming Pharmaceutical MFG. Co., Ltd

Sigachi Industries Pvt. Ltd., among others

Microcrystalline Cellulose Industry Developments

May 2022: Asahi Kasei had established a group-wide data management platform called “DEEP” (Data Exploration and Exchange Pipeline) to accelerate digital transformation (DX) throughout the Asahi Kasei Group, and started its operation in April 2022. DEEP has already been utilized in the analysis of several businesses, and is expected to make further contribution to the enhancement of management and businesses.

September 2023: JRS Pharma GmbH & Co. KG announced that it has launched a new grade of MCC called Avicel® HFE Pro. Avicel® HFE Pro is a high-performance MCC that is designed to meet the demanding requirements of the pharmaceutical industry. It is suitable for use in a wide range of pharmaceutical applications, including tablet and capsule formulations, oral suspensions, and topical creams and gels.

January 2021: Asahi Kasei's specialty solutions SBU had announced that they will build a second plant for microcrystalline cellulose at its Mizushima Works in Kurashiki, Okayama, Japan. The expansion is expected to be completed by 2023’s spring season. Asahi Kasei currently manufactures Ceolus, a microcrystalline cellulose used primarily in pharmaceuticals as tablet binder, in Nobeoka, Miyazaki, Japan. Through this expansion Asahi Kasei will enhance its market presence in Japan and adjoining countries

Microcrystalline Cellulose Market Segmentation

Microcrystalline Cellulose Source Outlook

Wood Based

Non-wood Based

Microcrystalline Cellulose End-Use Industry Outlook

Pharmaceuticals

Food & Beverages

Cosmetic & Personal Care

Microcrystalline Cellulose Regional Outlook

North America
- US
- Canada

Europe
- Germany
- France
- UK
- Italy
- Russia
- Spain
- Rest of Europe

Asia-Pacific
- China
- Japan
- India
- South Korea
- Australia & New Zealand
- Rest of Asia-Pacific

Latin America
- Mexico
- Brazil
- Argentina
- Rest of Latin America

Middle East & Africa
- Turkey
- GCC Countries
- South Africa
- Rest of the Middle East & Africa

Microcrystalline Cellulose MCC Companies

Leading companies partner with us for data-driven Insights

Kindly complete the form below to receive a free sample of this Report

Please fill in Business Email for Quick Response

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Purchase Option
	Single User	$ 4,950
	Multiuser License	$ 5,950
	Enterprise User	$ 7,250
Compare Licenses

Tailored for You

Dedicated Research on any specifics segment or region.
Focused Research on specific players in the market.
Custom Report based only on your requirements.
Flexibility to add or subtract any chapter in the study.
Historic data from 2014 and forecasts outlook till 2040.
Flexibility of providing data/insights in formats (PDF, PPT, Excel).
Provide cross segmentation in applicable scenario/markets.

FEATURES	LICENCE TYPE
FEATURES	Single User	Multiuser Licence	Enterprise User
Price	$ 4,950	$ 5,950	$ 7,250
Maximum User Access Limit	1 User	Upto 10 Users	Unrestricted Access Throughout The Organization.
Free Customization
Direct access to the Analyst
Deliverable Format
Deliverable Format
Platform Access
Discount on Your Next Purchase	10%	15%	10%
Printable Versions